localised prostate cancer
Localised prostate cancer
... organ-confined prostate cancer. Localised prostate cancer often grows slowly – or might not grow at all – and has a low risk of ...slow-growing localised prostate ...
12
Forum. Advances in radiation therapy for prostate. cancer. Abstract. Radiation therapy for localised prostate. cancer
... 2. Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria. Email: [email protected] Abstract The last decade has seen several new treatment technologies being incorporated into the ...
6
The decision-making role of the patient in localised prostate cancer treatment
... their cancer diagnosis and treatment, which may have contributed to the rising proportion of patients taking an active approach in the decision making ...with localised prostate cancer - ...
14
Randomised Controlled Trials Remain the Key to Progress in Localised Prostate Cancer.
... Over the last 2 yr, there has been an unprecedented wealth of randomised controlled trials (RCTs) illuminating outcomes in localised prostate cancer (PCa). Several thousand patients have been ...
8
Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer.
... of prostate adenocarcinoma diagnosed by TURP were identified from six cancer registries in Great ...clinically localised disease, as described previously (Cuzick et al, ...clinically localised ...
9
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
... Trans-Atlantic Prostate Group (TAPG) of clinicians and scientists from the United States and the United Kingdom have assembled the largest cohort of prostate cancers treated by conservative means with both ...
6
The cost utility of open prostatectomy compared with active surveillance in early localised prostate cancer
... There exists no evidence from RCTs for AS [16]. Because AS implies close monitoring and curative treatment when necessary, it can reasonably be assumed that an AS strategy is more effective in avoiding PC spe- cific ...
15
Quality of life outcomes after primary treatment for clinically localised prostate cancer: A systematic review
... This document is the author deposited version. You are advised to consult the publisher's version if you wish to cite from it. Published version LARDAS, Michael, LIEW, Matthew, VAN DEN BERGH, Roderick C., DE SANTIS, ...
14
Quality of life outcomes after primary treatment for clinically localised prostate cancer: A systematic review
... clinically localised prostate cancer: A systematic review LARDAS, Michael, LIEW, Matthew, VAN DEN BERGH, Roderick C., DE SANTIS, Maria, BELLMUNT, Joaquim, VAN DEN BROECK, Thomas, CORNFORD, Philip, ...
9
Quality of life outcomes after primary treatment for clinically localised prostate cancer: A systematic review
... Published version LARDAS, Michael, LIEW, Matthew, VAN DEN BERGH, Roderick C., DE SANTIS, Maria, BELLMUNT, Joaquim, VAN DEN BROECK, Thomas, CORNFORD, Philip, CUMBERBATCH, Marcus G., FOSSATI, Nicola, GROSA, Tobias, HENRY, ...
20
Quality of life outcomes after primary treatment for clinically localised prostate cancer: A systematic review
... This document is the author deposited version. You are advised to consult the publisher's version if you wish to cite from it. Published version LARDAS, Michael, LIEW, Matthew, VAN DEN BERGH, Roderick C., DE SANTIS, ...
10
Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer : a systematic review
... and prostate cancer outcomes, and in particular cause-specific ...with localised prostate cancer 143 showed that in some research protocols PSAV and PSADT were already used, in ...
260
Focal Therapy for Localised Prostate Cancer
... Minimally-Invasive Prostate Intervention (MIPI) Group Division of Surgery and In terventional Science, UCL Prof Mark Emberton (Honor ary Consultant Urologist) Mr Hashim Ud[r] ...
33
Transperineal Permanent Brachytherapy of Localised Prostate Cancer
... Since prostate cancer is believed to be an indolent disease with a relatively slow-growing pattern, most patients will die from other ...of prostate cancer is a strong contraindication for ...
10
Active surveillance strategy for patients with localised prostate cancer
... clinically localised PCa and a histopathological assessment according to the WHO defini- tion, found an indolent course during the first 15 years in all patients, followed by a steep increase of PCa mortality in ...
17
A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer
... of Cancer; EPIC = Expanded Prostate Cancer Index Composite; FACT-P = Functional Assessment of Cancer Therapy specific for prostate cancer; GETUG = Groupe d’Etude des Tumeurs ...
23
The role of focal therapy in the management of localised prostate cancer: a systematic review
... Objective: To systematically review the existing literature on baseline characteristics of the target population; preoperative evaluation to localise disease; and perioperative, functional, and disease control outcomes ...
20
Psychological and social factors influencing patients' treatment selection for localised prostate cancer
... their cancer was not aggressive, selected to undergo a radical pros‐ tatectomy because they believed it to be most effective at curing their cancer, and selected EBRT because of the reduced risk of ...
16
Stereotactic radiotherapy, proton therapy and irreversible electroporation for the treatment of localised prostate cancer
... of Cancer Quality of Life Group entwickelte multidimensionale EORTC QLQ-C30 Fra- gebogen umfasst 30 Fragen über 10 Subskalen und dient zur Beurteilung der Lebensqualität onkologischer ...
114
Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: A comparison of observational cohorts
... large cancer populations and compared the results to those obtained from a model derived from a reference, noncancer population ...in cancer-free men, whereas in men diagnosed with PCa following clinical ...
15